Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Mar 28, 2024 2:51pm
74 Views
Post# 35958691

RE:RE:RE:RE:RE:Voting for AGM

RE:RE:RE:RE:RE:Voting for AGM

If it looks like a Soleus nominee if it walks like a Soleus nominee then it is a Soleus nominee!!!
Of course he cannot be a IQ nominee  who will be a Quebec resident 
 

PWIB123 wrote: The Soleus connection is pure speculation, but the timing of their filing to become an activist shareholder where they specificly stated among other things that they wanted a board pick.  They also wanted to potentially consider breaking apart the company, selling, and any other option could be on the table if it adds value.  Interesting that this guys background is right up those areas.  I'd like to believe Zwick is a Soleus pick.

I wouldn't underestimate pride and greed.  I'm sure he will have a chance to participate in rich profits, but he's clearly a man that enjoys a good challenge.  That said, he's smart too, and wouldn't accept the position unless he felt he had the ability to influence change.  They obviously need him.  

In short, the only way I would accept that position is if I had a pre-cleared pathway to institute change.  I think we should think of this as a positive.

juniper88 wrote:
PWIB123 and Manequin I am on the same page with both of you on this.

One thing I have to wonder about.  Why would someone with Zwick's seemingly considerable talent and experience possibly touch the like of Thera with a ten feet pole, let alone become a board member?

Any thoughts? 
 
PWIB123 wrote: It doesn't even matter to me if they show efficacy or have good results from TH-1902.  They've had too many blunders, too many mistakes, and have proven they are incapable of communicating properly or driving shareholder value.  I'm voting against every one of them except Zwick on the premise that they have yet to demonstrate any sense of proper leadership.  They may have protected themselves, but I'm still going to vote against them.

Trogarzon wrote: Again I will vote my shares against ALL execpt the new guy Zwick.  Also, I will ask everyone I know to vote their shares this year once again.  Unless they have really good efficacity in part 3 of P1 th1902 and it's not designed for that well they will be voted OUT.




PWIB123



 

<< Previous
Bullboard Posts
Next >>